Modified Citrus Pectin Treatment in Non-Metastatic Biochemically Relapsed Prostate Cancer: Results of a Prospective Phase II Study

Optimal therapy of biochemically relapsed prostate cancer (BRPC) after local treatment is elusive. An established modified citrus pectin (PectaSol(®), P-MCP), a dietary polysaccharide, is an established antagonist of galectin-3, a carbohydrate-binding protein involved in cancer pathogenesis. Based o...

Descripción completa

Detalles Bibliográficos
Autores principales: Keizman, Daniel, Frenkel, Moshe, Peer, Avivit, Kushnir, Igal, Rosenbaum, Eli, Sarid, David, Leibovitch, Ilan, Mano, Roy, Yossepowitch, Ofer, Margel, David, Wolf, Ido, Geva, Ravit, Dresler, Hadas, Rouvinov, Keren, Rapoport, Noa, Eliaz, Isaac
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8706421/
https://www.ncbi.nlm.nih.gov/pubmed/34959847
http://dx.doi.org/10.3390/nu13124295

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8706421/
https://www.ncbi.nlm.nih.gov/pubmed/34959847
http://dx.doi.org/10.3390/nu13124295

Ejemplares similares